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Purpose. Poly-4-hydroxybutyrate (P4HB) is a naturally derived, absorbable polymer. P4HB has been manufactured into PHASIX
Mesh and P4HB Plug designs for soft tissue repair. The objective of this study was to evaluate mechanical strength, resorption
properties, and histologic characteristics in a porcinemodel.Methods. Bilateral defects were created in the abdominal wall of 𝑛 = 20
Yucatan minipigs and repaired in a bridged fashion with PHASIX Mesh or P4HB Plug fixated with SorbaFix or permanent suture,
respectively. Mechanical strength, resorption properties, and histologic characteristics were evaluated at 6, 12, 26, and 52 weeks
(𝑛 = 5 each). Results. PHASIX Mesh and P4HB Plug repairs exhibited similar burst strength, stiffness, and molecular weight
at all time points, with no significant differences detected between the two devices (𝑃 > 0.05). PHASIX Mesh and P4HB Plug
repairs also demonstrated significantly greater burst strength and stiffness than native abdominal wall at all time points (𝑃 <
0.05), and material resorption increased significantly over time (𝑃 < 0.001). Inflammatory infiltrates were mononuclear, and both
devices exhibited mild to moderate granulation tissue/vascularization. Conclusions. PHASIX Mesh and P4HB Plug demonstrated
significant mechanical strength compared to native abdominal wall, despite significant material resorption over time. Histological
assessment revealed a comparable mild inflammatory response and mild to moderate granulation tissue/vascularization.
1. Introduction
Biological scaffold materials derived from dermis, peri-
cardium, and small intestine submucosa of human, bovine,
and porcine origin have been utilized over the last decade
for soft tissue repair applications such as hernia repair [1],
breast reconstruction [2], staple-line reinforcement [3], and
orthopedic applications [4]. These scaffold materials are
particularly useful in clean-contaminated or contaminated
settings due to their rapid revascularization and clearance of
bacteria [5, 6]. Permanent, synthetic polymer mesh materials
are not typically utilized in these settings due to risk of
infection [7]. Biological scaffolds are also utilized as an
alternative to fascial closure when there is excessive tension
on the wound, when tissue loss makes closure especially
difficult, or in “damage-control”/abdominal compartment
settings in which the abdomen must be left open until the
patient is stabilized [8]. In these settings, scaffolds are utilized
to protect the abdominal contents, typically until granulation
of the wound occurs and a split-thickness skin graft can be
applied. Although biological scaffolds presentmany attractive
advantages, these materials are also extremely expensive,
exhibit substantial scaffold variability, and provoke patient-
specific immunological responses. Thus, absorbable poly-
mer scaffolds have recently been developed (Table 1). Early
designs of absorbable polymer scaffolds included materials
such as DEXON (Covidien, Mansfield, MA) and VICRYL
(Ethicon, Inc., Somerville, NJ).
According to the Instructions for Use, DEXON is com-
prised of polyglycolic acid (PGA), and it degrades in vivo
via hydrolysis. Full resorption of the PGA is expected to be
complete in approximately 60–90 days (2-3 months). Animal
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Table 1: Description of composition, degradation mechanism, and expected human resorption time of absorbable mesh materials.
Mesh type Composition Degradation mechanism Resorption time
DEXON Covidien(Mansfield, MA) Polyglycolic acid (PGA) Hydrolysis 2-3 months
VICRYL Ethicon, Inc.(Somerville, NJ)
Copolymer of glycolide









TIGR Matrix Novus Scientific(Uppsala, Sweden)






Fiber no. 2 Copolymer of polylactide and





Poly-4-hydroxybutyrate (P4HB) Hydrolysis and enzymaticmechanisms 12–18 months
studies have shown that DEXON is quickly resorbed and
associated with hernia formation after just 14 days due to
central mesh failure [9]. By 90 days, greater than 80% of the
scaffolds were fully resorbed in that particular animal study
[9]. Clinical studies have shown that DEXON has primarily
been utilized in damage control situations to cover the open
abdomen until granulation tissue is present and a skin graft
can be applied [10]. However, subsequent development of a
ventral hernia has also been observed in these patients. In
one study, 6 of 8 (75%) patients developed a hernia after
DEXON placement [11]. The authors concluded that the
DEXONmesh was useful for providing a temporary support
for the abdominal wall but would likely require a ventral
hernia repair with placement of a permanent mesh once the
contamination was resolved, making this material a less than
ideal long-term solution.
VICRYL is a copolymer of glycolide and lactide which
also degrades in vivo through hydrolysis. According to its
Instructions for Use, VICRYL loses 77% of its strength in
the first 14 days (0.5 months) in a rat model, and it is fully
resorbed in approximately 60–90 days (2-3 months). Clini-
cally, VICRYL has been utilized primarily in damage-control
applications as a buttress to the abdominal wall [12] or as a
prophylactic measure to prevent incisional hernia formation
[13]. Animal studies have shown that the tensile strength of
the rat abdominal wall at 30 and 60 days is equivalent whether
VICRYL mesh or biological scaffolds were utilized (Surgisis
and AlloDerm) [14]. However, collagen deposition and neo-
vascularization were greater for the biological scaffolds than
for VICRYL [14]. This could be explained by the decreased
pH and associated increase in inflammation observed at
the wound site as the VICRYL mesh degrades [14]. Pro-
nounced inflammation, reduced tissue ingrowth, and greater
angiogenesis were observed for VICRYL mesh compared to
permanent PROLENE and ULTRAPRO meshes in another
animal study involving a hamster model [15]. The authors of
that study concluded that the more aggressive foreign body
response incited by the resorbable VICRYL mesh did not
lead to better tissue incorporation as predicted [15]. In a
similar study, tissue ingrowth was also unsatisfactory for
the absorbable VICRYL mesh when compared to permanent
synthetic materials such as polypropylene and expanded
polytetrafluoroethylene in a rabbit model [16].
Overall, both DEXON and VICRYL scaffolds lose
mechanical strength and are resorbed fairly quickly, making
them less than ideal for hernia repair applications which
require more long-term support of the repair site until
tissue remodeling is complete. Thus, more recent absorbable
scaffold designs have been developed which utilize long-
lasting polymers that degrade more slowly. Scaffolds such
as GORE BIO-A (W.L. Gore and Associates, Inc., Flagstaff,
AZ), TIGR Matrix (Novus Scientific, Uppsala, Sweden), and
PHASIXMesh (C. R. Bard, Inc./Davol Inc., Warwick, RI) fall
into this category.
GORE BIO-A is a copolymer of poly(glycolide: trimethy-
lene carbonate) that degrades in vivo through both hydrolytic
and enzymatic mechanisms and is fully resorbed within
approximately 180 days (6 months) according to the Instruc-
tions forUse. In a ratmodel withmethicillin-resistant Staphy-
lococcus aureus (MRSA) contamination, bacteriawere cleared
from the GORE BIO-A mesh more effectively than either
VICRYL or TIGR Matrix at the 106 inoculum [17]. However,
at the 104 inoculum, all three scaffolds performed equally.
Overall, all three scaffolds exhibited reduced tensile strength
and increased rate of mesh failure regardless of scaffold com-
position [17]. GOREBIO-Ahas also been utilized in a number
of clinical applications including Amyand hernia repair [18],
open elective hernia repair [19], paraesophageal/hiatal hernia
repair [20], suture line reinforcement [20], pelvic floor rein-
forcement [20], and breast reconstruction [20].The outcomes
thus far have been promising with low rates of recurrence,
infection, and pain. However, the majority of these studies
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have been case reports or very small series (i.e., less than
10 patients). Larger, more comprehensive clinical trials are
needed to fully understand the long-term capabilities of this
scaffold.
TIGR Matrix is knitted from two fibers having different
resorption rates. According to the Instructions for Use, the
first fiber makes up approximately 40% of the overall mesh
by weight and is a copolymer of polyglycolide, polylactide,
and polytrimethylene carbonate. This fiber degrades in vivo
through hydrolysis, loses substantial mechanical strength
in the first 14 days (0.5 months), and is fully resorbed in
approximately 120 days (4 months). The second fiber makes
up approximately 60% of the overall mesh by weight and is
a copolymer of polylactide and polytrimethylene carbonate.
This fiber also degrades in vivo through hydrolysis, but it
retains its mechanical strength longer than the first fiber.
It begins to demonstrate loss of mechanical strength after
approximately 270 days (9 months) and is fully resorbed in
approximately 1095 days (36 months). TIGRMatrix has been
evaluated in a long-term animal model, and a clinical trial is
currently underway. In the animal study, TIGR Matrix was
compared to permanent polypropylene mesh in sheep with
full thickness abdominal wall defects over the course of 4, 9,
15, 24, and 36 months [21]. The results showed a typical long-
term inflammatory response to the permanent polypropylene
contrastedwith a gradual resorption of the TIGRMatrix until
it was fully resorbed at 36 months [21].The TIGRMatrix also
exhibited collagen deposition at the repair site that increased
over time and eventually resembled native connective tissue
[21]. In the clinical trial, forty subjects were enrolled (𝑛 = 40)
and followed for 1 year after placement of TIGR Matrix to
repair a primary inguinal hernia [22]. Pain and recurrence
were evaluated at 0.5, 1, 3, 6, and 12 months, and pain scores
were reduced from an average of 17.4 before surgery to 0.3
after just 6 months [22].
PHASIXMesh andP4HBPlug designs are both fabricated
from poly-4-hydroxybutyrate (P4HB). P4HB is a natural
polymer from the class of polyhydroxyalkanoates [23]. In
nature, these polymers are produced by microorganisms for
the purpose of regulating energy metabolism [23]. In the
case of PHASIX Mesh, P4HB is a naturally derived, fully
absorbable polymer produced by Escherichia coliK12 bacteria
via transgenic fermentation techniques [23]. P4HB has a
chemical structure very similar to many of the synthetic
polyester polymers, but because it is biologically derived
rather than chemically synthesized, P4HB does not contain
any residues from metal catalysts that are typically utilized
during chemical synthesis of other polyester polymers [23].
P4HB degrades in vivo through both hydrolysis and a
hydrolytic enzymatic digestive process and is fully resorbed
in approximately 365–545 days (12–18 months) according to
the Instructions for Use. The resulting by-products (carbon
dioxide andwater) aremetabolized very quickly via the Krebs
Cycle and beta-oxidation [23]. Unlike absorbable scaffolds
such as DEXON and VICRYL, whose by-products decrease
the pHat thewound site, degradation of P4HB is not as acidic,
whichmay reduce the inflammatory response associatedwith
these materials [23]. In addition, P4HB has been shown to
degrade more slowly than PGA, yielding more gradual loss
of mechanical strength [23]. This is advantageous in applica-
tions such as hernia repair in which the rate of degradation
should ideally match the rate of remodeling and neotissue
deposition at the repair site. A gradual change in mechanical
properties is also advantageous because it leads to a gradual
transfer of the load from the scaffold back to the tissue,
whichmay help to prevent hernia recurrence. P4HB has been
evaluated in a number of animal studies over the past decade,
particularly those investigating cardiovascular applications
such as tissue engineered trileaflet heart valves [24], artery
augmentation patches [25], and small diameter vascular
grafts [26], as well as development of P4HB as a suture
material [27]. However, this is the first study to evaluate
this material specifically for hernia repair applications. Thus,
the purpose of this study was to determine the mechanical
properties, resorption profile, and histological characteristics
of PHASIX Mesh and P4HB Plug compared to the native
abdominal wall when utilized to bridge a surgical defect in
a porcine model.
2. Materials and Methods
2.1. Materials. PHASIX Mesh is comprised of a fully re-
sorbable polymer monofilament (poly-4-hydroxybutyrate,
P4HB) that is knitted into a flat sheet configuration as shown
in Figure 1(a). The P4HB Plug design is also comprised
of P4HB monofilament, but it is preformed into a three-
dimensional shape with a fluted outer layer and inner layers
or “petals” attached at the tip as shown in Figure 1(b).
2.2. Preimplantation Characterization
2.2.1. Suture Retention Strength Testing. Twelve specimens
(𝑛 = 12) measuring 2.5×5.1 cm (1×2 in) were prepared from
PHASIX Mesh and subjected to suture retention testing at
time zero,𝑇
0
(i.e., prior to implantation). Six of the specimens
(𝑛 = 6) were oriented such that the load applied during
testing was parallel to the longest dimension of the mesh
interstices. The other six (𝑛 = 6) specimens were oriented
such that the load applied during testing was perpendicular
to the longest dimension of the mesh interstices. A custom
test fixture was utilized in which the mesh specimen was
loaded vertically in the Instron machine (Instron, Norwood,
MA) with a gauge length of 2.5 cm (1 in) and clamped
along the upper edge using pneumatic grips set to 60 psi. A
stainless steel wire with a diameter of 0.36mm (simulating
0 polypropylene suture material) was passed through the
mesh 1.0 cm from the bottom edge of the mesh. This was
done to capture at least two rows of mesh interstices. Each
specimen was tested in tension at a rate of 300mm/min
(12 in/min) until the suture pulled through the mesh. The
“suture retention strength” was recorded as the maximum
load sustained by the mesh in units of Newtons (N).
2.2.2. Tear Resistance Testing. Tear resistance testing was
based on the American Society for Testing and Materials
(ASTM) specification #D2261-07a. For this type of testing,
twelve mesh specimens (𝑛 = 12) measuring 2.5 × 7.6 cm
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Figure 1: (a) PHASIXMesh comprised of a fully resorbable polymer (poly-4-hydroxybutyrate, P4HB) monofilament knitted into a flat sheet
configuration. (b) P4HB Plug comprised of a fully resorbable polymer (poly-4-hydroxybutyrate, P4HB) monofilament preformed into a
three-dimensional shape with a fluted outer layer and inner layers or “petals” attached at the tip.
(1 × 3 in) were prepared from PHASIX Mesh and subjected
to tear resistance testing at time zero, 𝑇
0
(i.e., prior to
implantation). A 2.5 cm (1 in) slit was cut from the center of
the 2.5 cm edge of the specimen toward the center of themesh
to form two tabs. The left tab was clamped in the upper grip
of the Instron machine using a pneumatic grip set to 60 psi,
and the right tab was clamped in an identical fashion in the
lower grip. This arrangement yielded a 2.5 cm gauge length
(1 in). Six of the specimens (𝑛 = 6) were oriented such that
the load applied during testing was parallel to the longest
dimension of the mesh interstices. Conversely, the other six
(𝑛 = 6) specimens were oriented such that the load applied
during testing was perpendicular to the longest dimension of
the mesh interstices. The test was conducted in tension at a
rate of 300mm/min (12 in/min) until the specimen tore in
half. The “tear strength” was recorded as the maximum load
sustained by the mesh in units of Newtons (N).
2.2.3. Ball Burst Testing. Six circular specimens (𝑛 = 6)
measuring 7.5 cm in diameter (3 in diameter) were prepared
from PHASIX Mesh and subjected to ball burst testing at
time zero, 𝑇
0
(i.e., prior to implantation). Mesh orientation
was not considered due to the biaxial nature of the test. For
this reason, only one set of mesh specimens was prepared
with no indication of the orientation of the mesh interstices
during testing. A custom test fixture was fabricated based
on ASTM specification #D3787-07. Two circular stainless
steel rings were utilized to clamp the mesh specimen to
prevent slipping during the test.Then, a 2.5 cmdiameter (1 in)
stainless steel ball was applied in compression at a rate of
300mm/min (12 in/min) until it burst through the mesh.The
ultimate tensile stress and the strain at a stress of 16N/cm
were recorded in units of N/cm and percent, respectively.
2.3. Animal Model
2.3.1. Study Compliance. The Institutional Animal Care and
Use Committee (IACUC) of the CBSET, Inc. facility (Lex-
ington, MA) where the study was conducted approved the
experimental protocol prior to the start of the study, and
standard operating procedures were followed at all times.
2.3.2. Surgical Technique. Twenty (𝑛 = 20) castrated male,
Yucatan minipigs weighing 33.7–41.8 kg (at surgery) were
acquired for the study and acclimated to the facility for a
minimum of 21 days. Animals were fasted for at least 12
hours prior to surgery. On themorning of surgery, Buprenor-
phine (0.03mg/kg, IM) and Rimadyl (2.2mg/kg, PO) were
administered. Following sedation, the animalswere intubated
and maintained under anesthesia with 0.5–5%, isoflurane
inhalant anesthetic, to effect. The animals were placed in
dorsal recumbency, and the ventral abdomen was prepared
for aseptic survival surgery by shaving the entire abdominal
region, cleaning the operative area with three alternating
scrubs of povidone-iodine solution and 70% isopropyl alco-
hol solution, and applying sterilized surgical drapes over the
entire field. Following preparation of the abdomen, a midline
laparotomy (∼30 cm) was performed. Two, 3 cm diameter
(1.2 in diameter) bilateral muscular defects were created in
the anterior abdominal wall using a preperitoneal approach
(i.e., the peritoneum remained intact). The surgical defects
were not closed and were bridged with a 10.2 cm diameter
(4 in diameter) PHASIX Mesh on the right side (Figure 2(a))
or a 7.9 cm diameter (3.1 in diameter) P4HB Plug on the
left side (Figure 2(b)). The PHASIX Mesh was placed in the
preperitoneal plane (bridging the defect) and fixated circum-
ferentially with approximately 𝑛 = 16 SorbaFix Absorbable
Fixation Device constructs comprised of poly(D,L-lactide).
The P4HB Plug was placed in the preperitoneal plane as an
onlay mesh bridging the defect and fixated circumferentially
with approximately 𝑛 = 12 permanent PROLENE (2-
0) sutures. The abdominal midline was then repaired via
standard closure techniques, and the skin was tattooed to
define the cranial, caudal, medial, and lateral aspects of
each device to facilitate identification at the time of explant.
The animals were recovered from anesthesia and allowed
free access to food and water ad libitum. Buprenorphine
(0.02mg/kg, IM) was administered every 4–12 hours, and
Rimadyl (2.2mg/kg, PO) was administered every 24 hours
for 72 hours postoperatively.
The abdominal region of each animal was examined daily
to assess the condition of the wound and the subcutaneous
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Figure 2: (a) PHASIX Mesh placed in the preperitoneal plane (bridging the defect) and fixated circumferentially with approximately 𝑛 = 16
SorbaFix Absorbable Fixation Device constructs. (b) P4HB Plug placed in the preperitoneal plane as an onlay mesh bridging the defect and
fixated circumferentially with approximately 𝑛 = 12 permanent PROLENE (2-0) sutures.
tissues for evidence of herniation, diastasis, seromas, and/or
hematomas. Animals were survived for 6, 12, 26, or 52
weeks (𝑛 = 5 in each group), followed by euthanasia.
Humane euthanasia was carried out after sedation with
Telazol (4mg/kg, IM) and anesthesia via inhalant isoflu-
rane. Euthanasia was achieved by administering an overdose
of sodium pentobarbital (60–150mg/kg, intravenously, to
effect) in accordance with the American Veterinary Medical
Association (AVMA) Panel of Euthanasia and Journal of
the American Veterinary Medical Association. Following
euthanasia, the abdominal skin was dissected from the entire
abdomen, and the abdominal wall (including the 2 surgical
defects) was excised, photographed, and placed in saline
solution (0.9% NaCl) for subsequent mechanical testing. A
representative specimen from each PHASIXMesh and P4HB
Plug repair was also harvested for histological and molecular
weight analyses. This specimen was split into two pieces.
One half was placed in 10% neutral buffered formalin for
histological analysis, and the other was placed in an empty
specimen jar for molecular weight analysis.
2.4. Postimplantation Characterization. The repair sites (i.e.,
abdominal wall tissue plus test device as a composite spec-
imen) were subjected to ball burst testing to evaluate the
peak load and relative stiffness of each repair site compared
to native abdominal wall. The peritoneum was carefully
removed from both of the repair sites and the native abdom-
inal wall sites prior to testing to eliminate the contribution of
the peritoneum and to allow assessment of the strength of the
repair site alone.
2.4.1. Mechanical Testing. The repair sites and native abdom-
inal wall sites were subjected to burst testing using an
Instron servohydraulic test frame (Instron, Norwood, MA).
A 0.95 cm (0.375 in) diameter ball was applied in compression
at a rate of 25.4mm/min (1 inch/min) until the ball burst
through. The peak load (ball burst force in units of Newtons,
N) sustained by each specimen was recorded, and the relative
stiffness was calculated from the slope of the line formed
when load was graphed versus elongation (units = N/mm).
Relative stiffness was taken from the slope of the line in the
region of 30–80% of the peak load.
2.4.2. Gel Permeation Chromatography (GPC). Explanted
PHASIXMesh and P4HBPlug specimens were enzymatically
digested and manually cleaned to remove residual tissue
prior to gel permeation chromatography (GPC) analysis.
GPC was conducted to quantify the molecular weight of the
mesh material remaining at each time point. Specimens were
placed in 50mL tubes containing 40mL collagenase (type I)





, pH 7.4). The tubes were placed on a
shaker (50 rpm) and incubated at 37∘C to digest the tissue.
After overnight incubation (∼17 hours), the specimens were
removed from the buffer and manually cleaned of tissue. The
cleaned specimens were rinsed in distilled water, followed by
70% ethanol, and dried prior to GPC analysis. Cleaned mesh
specimens were dissolved at 1mg/mL in chloroform, filtered
using a 0.45 𝜇m filter to remove undigested particulates, and
95 𝜇L of this solution was then injected onto a GPC column
for analysis. GPC was performed in chloroform at 1ml/min
using a Polymer Labs, PLgel column (5 micron, mixed C, 300
× 7.5mm) with an Agilent 1100 Series HPLCwith RI detector.
Calibrationwas conducted againstmonodisperse polystyrene
standards. Molecular weight is reported below in units of
Daltons (Da).
2.4.3. Histology. All histological assessments were conducted
by a board-certified veterinary pathologist (CBSET, Lexing-
ton, MA). The explanted specimens were immersion-fixed
in 10% neutral buffered formalin, cut into cross-section,
and paraffin-embedded for further processing. Paraffin-
embedded sections were microtomed (4-5 𝜇m), mounted
onto glass slides, and stained with hematoxylin and eosin
(H&E), Masson’s Trichrome, and Picrosirius Red to char-
acterize the host inflammatory/fibrotic response, collagen
deposition/remodeling, and absorption properties associated
with each specimen based on a standardized scoring system.
Specimens were scored for inflammatory cell infiltrates (neu-
trophils, eosinophils, macrophages, lymphocytes, giant cells),
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neovascularization, fibroplasia (granulation tissue), hemor-
rhage, necrosis, and fibrosis using the following scoring
system as described previously [28]:





Picrosirius Red stained slides were viewed via cross-
polarization microscopy. Newly deposited, type III collagen
appeared green, while mature, type I collagen appeared red
or orange under these conditions. A score of “1” was assigned
when green (type III collagen) predominated, a score of “2”
was assigned when there was a mixture of green, yellow, and
yellow-orange, and a score of “3” was assigned when red-
orange (type I collagen) predominated.
2.4.4. Statistical Analysis. Systat software (version 12.0, Systat
Software, Inc., San Jose, CA) was utilized to perform all sta-
tistical analyses. For continuous data in which three or more
groups of data were compared, (i.e., peak burst load, relative
stiffness, molecular weight) a one-way analysis of variance
(ANOVA) was performed followed by a Fisher’s LSD post-
test as appropriate. For scores such as histological parameters
in which three or more groups of data were compared, a
nonparametric test (Kruskal-Wallis) was performed followed
by a Dunn’s posttest as appropriate. Statistical significance
was set at the 𝑃 < 0.05 level. All data are reported as mean ±
standard error of the mean (SEM) except the histological
parameters in which the median is reported.
3. Results
3.1. Preimplantation Characterization
3.1.1. Suture Retention Strength Testing. When PHASIXMesh
was evaluated in the direction parallel to the longest dimen-
sion of the interstices, the suture retention strength was
59.16 ± 5.7 N, which was greater than the 20N suture reten-
tion strength suggested for hernia repair applications [29, 30].
Similarly, when tested in the direction perpendicular to the
longest dimension of the interstices, the suture retention
strength of PHASIX Mesh was again greater than 20N at
49.10 ± 2.3 N.
3.1.2. Tear Resistance Testing. When PHASIX Mesh was
evaluated in the direction parallel to the longest dimension
of the interstices, the tear resistance strength was 30.33 ±
3.1 N, whichwas greater than the 20N tear resistance strength
suggested for hernia repair applications [29, 30]. Similarly,
when tested in the direction perpendicular to the longest
dimension of the interstices, the tear resistance strength of
PHASIX Mesh was again greater than 20N at 29.48 ± 2.4 N.
3.1.3. Ball Burst Testing. When subjected to ball burst testing,
the maximum compressive load sustained by the PHASIX
Mesh was 486.97 ± 12.6 N, with a tensile strength of 140.70 ±
5.4N/cm and a strain at a stress of 16N/cm of 15.43 ±
0.2%. Tensile strength greater than 50N/cm and strain in the
range of 10–30% are considered suitable properties for hernia
repair applications [29, 30]. Thus, PHASIX Mesh possessed




3.2.1. Observations during Survival Period. One animal died
prior to its expected time point for reasons unrelated to the
materials being evaluated in this study (i.e., sedation-related
complication). This animal was replaced with an additional
animal in order to maintain 𝑛 = 5 animals in each group. All
other animals survived until their expected time points.
3.2.2. Observations during Explantation of Devices. As shown
in Figures 3(a)–3(d) both devices (i.e., PHASIX Mesh and
P4HB Plug) and both types of fixation (i.e., SorbaFix
Absorbable FixationDevice fasteners andPROLENE sutures)
remained visible and intact at the repair sites at 6, 12, 26, and
52 weeks. No evidence of hernia or diastasis was documented
in any of the animals at any of the time points.
3.2.3. Burst Strength (N). As shown in Figure 4(a), the burst
strength of the native abdominal wall tissue remained stable
throughout the duration of the study with no significant
changes over time. At 6, 12, 26, and 52 weeks, the burst
strength of the native abdominal wall was 76.9± 6.3N, 62.8±
14.7N, 58.7 ± 9.4N, and 69.7 ± 13.6N, respectively. No
significant differences were detected between 6 and 12 weeks
(𝑃 = 0.788), between 12 and 26 weeks (𝑃 = 0.938), between
26 and 52 weeks (𝑃 = 0.834), or overall between 6 and 52
weeks (𝑃 = 0.891).
The burst strength of the abdominal wall repaired with
PHASIX Mesh also remained stable throughout the duration
of the studywith no significant changes over time. At 6, 12, 26,
and 52 weeks, the burst strength of the PHASIX Mesh repair
site was 294.0 ± 31.4N, 277.0 ± 14.8N, 217.6 ± 20.3N, and
260.7 ± 93.8N, respectively. No significant differences were
detected between 6 and 12 weeks (𝑃 = 0.746), between 12 and
26 weeks (𝑃 = 0.262), between 26 and 52 weeks (𝑃 = 0.414),
or overall between 6 and 52 weeks (𝑃 = 0.527).
The burst strength of the abdominal wall repaired with
P4HB Plug also remained stable throughout the duration of
the study with no significant changes over time. At 6, 12, 26,
and 52 weeks, the burst strength of the P4HB Plug repair site
was 215.2 ± 9.3N, 307.0 ± 36.0N, 231.0 ± 28.0N, and 298.5 ±
57.6N, respectively. No significant differences were detected
between 6 and 12 weeks (𝑃 = 0.086), between 12 and 26weeks
(𝑃 = 0.153), between 26 and 52 weeks (𝑃 = 0.204), or overall
between 6 and 52 weeks (𝑃 = 0.118).
PHASIX Mesh and P4HB Plug repairs demonstrated
similar burst strengths at 6, 12, 26, and 52 weeks with no
significant differences detected between the two devices at
any of the time points evaluated (𝑃 = 0.139, 𝑃 = 0.568,




Figure 3: Macroscopic appearance of PHASIXMesh (right side) and P4HB Plug (left side) at (a) 6 weeks, (b) 12 weeks, (c) 26 weeks, and (d)
















































Figure 4: Mechanical properties of the native abdominal wall compared to PHASIXMesh and P4HB Plug at 6, 12, 26, and 52 weeks: (a) peak
load (N) and (b) relative stiffness (N/mm).
abdominal wall sites repaired with PHASIX Mesh or P4HB
Plug materials both demonstrated significantly greater burst
strength compared to the native abdominal wall at 6, 12, 26,
and 52 weeks regardless of whether the mesh (𝑃 < 0.001,
𝑃 < 0.001, 𝑃 = 0.004, and 𝑃 = 0.001, resp.) or the plug
(𝑃 = 0.011, 𝑃 < 0.001, 𝑃 = 0.002, and 𝑃 < 0.001, resp.)
was utilized to bridge the defect.
3.2.4. Relative Stiffness (N/mm). As shown in Figure 4(b),
the relative stiffness of the native abdominal wall tissue
remained stable throughout the duration of the study with
no significant changes over time. At 6, 12, 26, and 52
weeks, the relative stiffness of the native abdominal wall
was 5.8 ± 1.2N/mm, 6.3 ± 1.6N/mm, 5.5 ± 0.7N/mm, and
6.5 ± 1.8N/mm, respectively. No significant differences were
detected between 6 and 12 weeks (𝑃 = 0.940), between 12 and
26 weeks (𝑃 = 0.910), between 26 and 52 weeks (𝑃 = 0.887),
or overall between 6 and 52 weeks (𝑃 = 0.917).
The relative stiffness of the abdominal wall repaired with
PHASIX Mesh also remained stable throughout the duration
of the studywith no significant changes over time. At 6, 12, 26,
and 52weeks, the relative stiffness of the PHASIXMesh repair
site was 22.2±4.7N/mm, 21.9±1.0N/mm, 28.7±7.8N/mm,
and 30.5±11.1N/mm, respectively. No significant differences
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were detected between 6 and 12 weeks (𝑃 = 0.970), between
12 and 26 weeks (𝑃 = 0.329), between 26 and 52 weeks (𝑃 =
0.799), or overall between 6 and 52 weeks (𝑃 = 0.234).
The relative stiffness of the abdominal wall repaired with
P4HB Plug also remained stable throughout the duration of
the study with no significant changes over time. At 6, 12, 26,
and 52 weeks, the relative stiffness of the P4HB Plug repair
site was 17.9±4.3N/mm, 22.5±2.4N/mm, 24.2±2.2N/mm,
and 33.8 ± 6.3N/mm, respectively. No significant differences
were detected between 6 and 12 weeks (𝑃 = 0.508), between
12 and 26 weeks (𝑃 = 0.804), or between 26 and 52 weeks
(𝑃 = 0.170). However, there was a slight trend toward greater
stiffness overall at 52 weeks compared to 6 weeks (𝑃 = 0.025).
PHASIX Mesh and P4HB Plug repairs demonstrated
similar relative stiffness at 6, 12, 26, and 52 weeks with
no significant differences detected between the two devices
at any of the time points evaluated (𝑃 = 0.533, 𝑃 =
0.940, 𝑃 = 0.512, and 𝑃 = 0.635, resp.). In addition,
porcine abdominal wall sites repaired with PHASIX Mesh or
P4HB Plug materials both demonstrated significantly greater
relative stiffness compared to the native abdominal wall at 6,
12, 26, and 52 weeks regardless of whether the mesh (𝑃 =
0.021, 𝑃 = 0.027, 𝑃 = 0.001, and 𝑃 = 0.001, resp.) or the plug
(𝑃 = 0.084, 𝑃 = 0.023, 𝑃 = 0.009, and 𝑃 < 0.001, resp.) was
utilized to bridge the defect. As demonstrated by a 𝑃 value of
0.084, the stiffness of the abdominal wall sites repaired with
P4HB Plug materials at 6 weeks did not quite reach statistical
significance and were only trending toward greater relative
stiffness compared to the native abdominal wall.
3.2.5. MolecularWeight (Da). As shown in Figure 5, PHASIX
Mesh andP4HBPlug repairs demonstrated similarmolecular
weights at 0, 6, 12, 26, and 52 weeks with no significant
differences detected between the two devices at any of the
time points evaluated (𝑃 = 0.804, 𝑃 = 0.640, 𝑃 = 0.268,
𝑃 = 0.150, and 𝑃 = 0.936, resp.).
The molecular weight of the PHASIX Mesh decreased
significantly over time with molecular weights of 240,510 ±
2,018Da, 204,282±4,457Da, 118,884±2,821 Da, and 44,434±
879Da at 6, 12, 26, and 52 weeks, respectively. Molecular
weight decreased significantly at each time point compared
to the preimplantation (i.e., 0 weeks) molecular weight of the
PHASIXMesh (300,397±972Da) with 𝑃 < 0.001 in all cases.
Furthermore, the molecular weight of the PHASIX Mesh
decreased progressively between 0 and 6 weeks, between 6
and 12 weeks, between 12 and 26 weeks, between 26 and 52
weeks, and overall between 0 and 52 weeks with 𝑃 < 0.001 in
all cases.
Similarly, the molecular weight of the P4HB Plug
decreased significantly over time with molecular weights of
242,190 ± 1,259Da, 208,288 ± 3,420Da, 124,126 ± 3,219Da,
and 44,148 ± 644Da at 6, 12, 26, and 52 weeks, respectively.
Molecular weight decreased significantly at each time point
compared to the preimplantation (i.e., 0 weeks) molecular
weight of the P4HB Plug (301,543 ± 110Da) with 𝑃 < 0.001
in all cases. Furthermore, the molecular weight of the P4HB
Plug decreased progressively between 0 and 6weeks, between


























Figure 5: Gel permeation chromatography results showingmaterial
resorption of PHASIXMesh and P4HB Plug increasing significantly
over time as evidenced by lower molecular weight over time.
weeks, and overall between 0 and 52 weeks with 𝑃 < 0.001 in
all cases.
3.2.6. Histology. As shown in Table 2, median scores for
inflammation were reported in the range of 2-3 for both
the PHASIX Mesh and the P4HB Plug at the early 6- and
12-week time points, and both consistently scored 2 at the
later 26- and 52-week time points. No significant differences
in inflammation scores were detected over time for either
the PHASIX Mesh or the P4HB Plug, and no significant
differences in inflammation scores were detected between the
mesh and plug designs at any of the time points (𝑃 > 0.05 in
all cases).
Macrophage scores of 2 were consistently reported for the
PHASIX Mesh at all time points with no significant changes
over time (𝑃 > 0.05). Interestingly, macrophage scores for
the P4HB Plug varied slightly over time with a median score
of 3 at the 6-week time point, trending toward a significantly
lower score of 1 at the 52-week time point (𝑃 < 0.05). Again,
no significant differences were identified between the mesh
and the plug designs at any of the time points evaluated (𝑃 >
0.05 in all cases).
Giant cell scores of 1 were consistently observed for both
the PHASIXMesh and the P4HBPlug at all of the time points.
No significant differences in giant cell scores were detected
over time for either the PHASIXMesh or the P4HB Plug, and
no significant differences in giant cells scores were detected
between the mesh and plug designs at any of the time points
(𝑃 > 0.05 in all cases).
Fibrosis/encapsulation scores for the PHASIX Mesh
varied slightly over time with a score of 4 at the 6-
week time point that trended toward a significantly lower
fibrosis/encapsulation score of 2 at the 12- and 52- week
time points (𝑃 < 0.05). No significant changes in fibro-
sis/encapsulation scores were observed for the P4HB Plug
with scores of 2-3 observed at all time points. In addition, no
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Table 2: Histology scores where 0 = absent/no response, 1 = minimal/barely detectable, 2 = mild/slightly detectable, 3 = moderate/easily
detectable, and 4 = marked/very evident for inflammation, macrophages, giant cells, fibrosis/encapsulation, and granulation/vascularization
and where 1 = predominantly green (type III collagen), 2 = mixture of green, yellow, and yellow-orange (mixture of type III and type I
collagen), and 3 = predominantly red-orange (type I collagen) for collagen morphology.
Histology scores
6 weeks 12 weeks 26 weeks 52 weeks
Mean ± SEM Median Mean ± SEM Median Mean ± SEM median Mean ± SEM Median
Inflammation
PHASIX
Mesh 2.6 ± 0.4 2.0 2.4 ± 0.4 3.0 2.2 ± 0.2 2.0 2.0 ± 0.0 2.0
P4HB
Plug 2.8 ± 0.4 3.0 2.0 ± 0.3 2.0 2.4 ± 0.2 2.0 1.6 ± 0.2 2.0
Macrophages
PHASIX
Mesh 2.0 ± 0.3 2.0 2.0 ± 0.3 2.0 2.0 ± 0.0 2.0 1.6 ± 0.2 2.0
P4HB
Plug 2.8 ± 0.4 3.0 1.6 ± 0.4 1.0 2.0 ± 0.4 2.0 1.0 ± 0.0 1.0
Giant cells
PHASIX
Mesh 1.2 ± 0.2 1.0 1.4 ± 0.2 1.0 1.2 ± 0.2 1.0 1.0 ± 0.0 1.0
P4HB




Mesh 3.8 ± 0.2 4.0 2.2 ± 0.2 2.0 2.6 ± 0.2 3.0 2.2 ± 0.2 2.0
P4HB




Mesh 2.8 ± 0.2 3.0 2.4 ± 0.2 2.0 2.6 ± 0.2 3.0 2.2 ± 0.2 2.0
P4HB




Mesh 1.8 ± 0.2 2.0 2.4 ± 0.2 2.0 2.2 ± 0.2 2.0 2.4 ± 0.2 2.0
P4HB
Plug 1.2 ± 0.2 1.0 2.4 ± 0.2 2.0 2.2 ± 0.2 2.0 2.2 ± 0.2 2.0
significant differences in fibrosis/encapsulation scores were
detected between themesh and plug designs at any of the time
points.
Granulation tissue/vascularization scores ranged from 2-
3 for both the PHASIX Mesh and the P4HB Plug at all
time points evaluated. The PHASIX Mesh scores alternated
between 3 and 2 at 6 and 12 weeks and again at 26 and 52
weeks, respectively, while the P4HB Plug scores were 2 at the
early 6- and 12-week time points and 3 at the later 26- and
52-week time points. However, no significant differences in
granulation tissue/vascularization scores were detected over
time for either the PHASIX Mesh or the P4HB Plug, and no
significant differences were detected between the mesh and
plug designs at any of the time points (𝑃 > 0.05 in all cases).
Collagen morphology scores of 2 were consistently
reported for the PHASIX Mesh at all time points with no
significant changes over time (𝑃 > 0.05). Similarly, collagen
morphology scores for the P4HB Plug were 1 at the early
6-week time point and 2 at all subsequent time points. As
with the mesh design, no significant changes in collagen
morphology were detected over time for the plug design (𝑃 >
0.05), and no significant differences were detected between
the mesh and plug designs at any of the time points (𝑃 > 0.05
in all cases).
4. Discussion
Poly-4-hydroxybutyrate (P4HB) is a naturally derived, fully
absorbable polymer produced by bacteria via transgenic fer-
mentation techniques. This material has been manufactured
into a number of configurations including the PHASIXMesh
and P4HB Plug, which are designed for soft tissue repair
applications such as hernia repair. Over the last decade, P4HB
materials have been evaluated in a number of animal studies,
particularly those investigating cardiovascular applications
such as tissue engineered trileaflet heart valves [24], artery
augmentation patches [25], and small diameter vascular
grafts [26], as well as development of P4HB as a suture
material [27]. However, the current study is the first of its
kind to evaluate this material specifically for hernia repair
applications.The objective of this study was to determine the
mechanical properties, resorption profile, and histological
characteristics of PHASIX Mesh and P4HB Plug designs
when utilized to bridge a surgical defect in the porcine
abdominal wall over a period of 6, 12, 26, or 52 weeks. To
accomplish this, abdominal wall sites repaired with PHASIX
Mesh and P4HB Plug materials were harvested at the end
of each implantation period and subjected to mechanical
testing, gel permeation chromatography, and histological
analysis to assess the strength of the repair, the amount of
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P4HB material remaining at the repair site, and the host
response to the P4HB material, respectively.
Mechanical testing revealed that the burst strength and
relative stiffness of the PHASIX Mesh and P4HB Plug
repaired sites were similar to each other at all four time points
evaluated with no significant differences detected between
the two devices for either of these parameters throughout the
course of the study (𝑃 > 0.05 in all cases). In addition, the
sites repaired with PHASIX Mesh and P4HB Plug materials
also exhibited significantly greater burst strength and relative
stiffness compared to the native abdominal wall at all time
points regardless of which device was utilized to bridge the
defect (𝑃 < 0.05 in all cases). These results indicate that the
P4HB material is capable of augmenting the strength of the
native porcine abdominal wall regardless of its configuration
as a mesh or plug design. It should also be noted that
burst strength and relative stiffness of the PHASIX Mesh
and P4HB Plug repaired sites remained stable and did not
change significantly between 6 and 52 weeks, suggesting that
scaffolds derived from the P4HB material are durable and
capable of maintaining support at the repair site over a 52-
week period in a porcine model.
Gel permeation chromatography was conducted to quan-
tify the molecular weight of the P4HB material remaining
at the repair site at each time point. The data showed that
PHASIX Mesh and P4HB Plug possessed similar molecular
weights at all time points with no significant differences
detected between the two devices at any time (𝑃 > 0.05
in all cases). These results correspond with the mechanical
testing data and demonstrate that the configuration of the
P4HB material does not significantly impact its resorption
profile. In addition, themolecular weight of both the PHASIX
Mesh and the P4HB Plug decreased significantly at each time
point compared to the corresponding preimplantation (i.e., 0
weeks) value and also decreased progressively between each
time point (i.e., between 0 and 6 weeks, between 6 and 12
weeks, between 12 and 26 weeks, between 26 and 52 weeks,
and overall between 0 and 52 weeks). These results indicate
that the P4HB material was significantly resorbed over time,
but as indicated by the mechanical testing data, significant
material resorption did not correspond with a significant
drop in mechanical strength at the repair site for either the
PHASIX Mesh or the P4HB Plug design.
In addition to mechanical testing and gel permeation
chromatography, histological analyses were also performed
in order to assess the host response to the P4HB mate-
rial comprising the PHASIX Mesh and the P4HB Plug
designs. No statistically significant changes were observed
over time for either the PHASIX Mesh or the P4HB Plug
with respect to histological parameters such as inflam-
mation, granulation tissue/vascularization, giant cells, or
collagen morphology. Inflammation scores and granulation
tissue/vascularization scores ranged from 2-3 for both the
mesh and the plug design indicating amild/slightly detectable
to moderate/easily detectable inflammatory response and
presence of granulation tissue and vascularization for both
devices at all time points. In addition, giant cells scores
were consistently reported as 1, indicating a minimal/barely
detectable presence of giant cells for both devices at all
time points. Similarly, collagen morphology scores were
consistently reported as 2, indicating a mixture of both
mature (type I, red and orange-red) and immature (type III,
green and yellow-green) collagen at all time points.
It should be noted that a few differences were observed
with respect to time of implantation. For instance fibro-
sis/encapsulation scores for the PHASIXMesh varied slightly
over time with a score of 4 at the 6-week time point that
trended toward a significantly lower fibrosis/encapsulation
score of 2 at the 12- and 52- week time points (𝑃 <
0.05). These scores correspond to marked/very evident fibro-
sis/encapsulation at the 6-week time point that was ultimately
improved tomild/slightly detectable fibrosis/encapsulation at
the later time points. Some degree of fibrosis/encapsulation
is expected in the presence of an implanted material such
as the PHASIX Mesh, and this response is expected to vary
over time with the tissue remodeling/wound healing process.
Similarly, the macrophage scores for the P4HB Plug varied
slightly over time with a score of 3 at the 6-week time
point, trending toward a significantly lower score of 1 at the
52-week time point (𝑃 < 0.05). These scores correspond
to moderate/easily detectable presence of macrophages at
the 6-week time point that ultimately improved to only
minimal/barely detectable presence ofmacrophages at the 52-
week time point.
In general, no statistically significant differences were
detected between the histological scores reported for the
PHASIX Mesh design versus the P4HB Plug design for any
of the parameters evaluated. These results suggest that the
host tissue response was most influenced by the chemical
composition of the device (i.e., poly-4-hydroxybutyrate)
rather than the structure of the device (i.e., mesh versus plug).
Inflammatory infiltrates associated with both devices were
predominantly mononuclear with an overall mild response
commonly associated with the implantation of a foreign
material. Similarly, both devices resulted in comparable,
mild to moderate granulation tissue/vascularization that
is expected in association with wound healing and tissue
remodeling, suggesting that the P4HB material performed
appropriately in terms of overall foreign body response
regardless of its configuration as a mesh or a plug.
5. Conclusions
PHASIXMesh and P4HB Plug provided durable scaffolds for
soft tissue repair in a porcine model. Both repairs demon-
strated significant mechanical strength compared to native
abdominal wall over a 52-week period, which remained
elevated despite significant material resorption over time
with no evidence of herniation and/or diastasis. In addition,
histological assessment revealed a comparable and mild
inflammatory response and mild to moderate granulation
tissue/vascularization associated with the P4HB material
regardless of its configuration as a mesh or a plug.
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